Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2012
09/27/2012CA2830516A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012CA2830129A1 Novel pyrimidine derivatives
09/27/2012CA2830081A1 Treatment of solid tumours
09/27/2012CA2829755A1 Treatment of proliferative disorders with a chemiluminescent agent
09/27/2012CA2829263A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012CA2824864A1 Cytotoxic benzodiazepine derivatives
09/27/2012CA2805805A1 Bendamustine anionic-catioinic cyclopolysaccharide compositions
09/26/2012EP2502938A2 Antibodies and immunoconjugates and uses therefor
09/26/2012EP2502937A2 Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use
09/26/2012EP2502936A1 Highly-functional mutant of humanized anti-egfr antibody variable region
09/26/2012EP2502924A1 Novel pyrimidine derivatives
09/26/2012EP2502914A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502911A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502649A1 Combination therapy using HDAC inhibitors and erlotinib for treating cancer
09/26/2012EP2502628A2 Polynucleotides and polypeptide sequences involved in cancer
09/26/2012EP2502627A1 Anti-cancer agent
09/26/2012EP2502626A1 Crystalline levofolinic acid and process for its preparation
09/26/2012EP2502625A1 Process for the preparation of crystalline levofolinic acid
09/26/2012EP2501705A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
09/26/2012EP2501694A1 Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib
09/26/2012EP2501691A1 Substituted pyrrolidine-2-carboxamides
09/26/2012EP2501689A1 Macrocyclic lactone derivatives for the treatment of cancer
09/26/2012EP2501672A2 Compositions and methods for treating hyperproliferative disorders
09/26/2012EP2501416A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives
09/26/2012EP2501413A2 Acid salt forms of polymer-drug conjugates and alkoxylation methods
09/26/2012EP2501412A1 Salt form of a multi-arm polymer-drug conjugate
09/26/2012EP2501385A1 Therapeutic combination comprising a cdc7 inhibitor and an antineoplastic agent
09/26/2012EP2501384A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
09/26/2012EP2501379A1 Combination
09/26/2012EP2501372A2 Intravenous infusion of curcumin and a calcium channel blocker
09/26/2012EP2501370A1 Methods and compositions for treating solid tumors and other malignancies
09/26/2012EP2501364A1 Parenteral formulations of gemcitabine derivatives
09/26/2012EP2056829B9 Using pi3k and mek modulators in treatments of cancer
09/26/2012CN1980696B Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
09/26/2012CN1799625B Preparation of officinal interleukin
09/26/2012CN1761480B APLIDINE for multiple myeloma treatment
09/26/2012CN102695722A Antibodies and epitopes specific to misfolded prion protein
09/26/2012CN102695714A Tubulin inhibitors
09/26/2012CN102695702A ABT-263 crystalline forms and solvates for use in treating BCL-2 protein related diseases
09/26/2012CN102695700A Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors
09/26/2012CN102695547A Methods and compositions for treating leukemia
09/26/2012CN102695520A Modulating interstitial pressure and oncolytic viral delivery and distribution
09/26/2012CN102695509A Novel photosensitizer formulations for oral administration
09/26/2012CN102695507A Combination therapy for treating cancer and diagnostic assays for use therein
09/26/2012CN102695504A Combination cancer therapy with HSP90 inhibitory compounds
09/26/2012CN102695503A Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
09/26/2012CN102690879A Application of CDK17 gene and expression product thereof
09/26/2012CN102690878A Application of CDK18 gene and expression product thereof
09/26/2012CN102690877A Application of CSNK1A1 gene and expression product thereof
09/26/2012CN102690876A Application of CSNK1G3 gene and expression product thereof
09/26/2012CN102690875A Application of CDK14 gene and expression product thereof
09/26/2012CN102690872A Application of TRIM28 gene and its expression product
09/26/2012CN102690871A Application of TEX14 gene and its expression product
09/26/2012CN102690870A Application of STC2 gene and its expression product
09/26/2012CN102690869A Application of MEP1A gene and its expression product
09/26/2012CN102690868A Application of PDK3 gene and its expression product
09/26/2012CN102690867A Application of NLK gene and its expression product
09/26/2012CN102690866A Application of TRPM7 gene and its expression product
09/26/2012CN102690865A MELK gene and application of its expression product
09/26/2012CN102690826A shRNA for specifically reducing human Aurora-A gene expression and application thereof
09/26/2012CN102690804A Polyethylene-glycol-modified recombinant homosapiensarginase I, preparation method thereof and application thereof
09/26/2012CN102690445A Mycobacterium polysaccharide, its preparation method and application
09/26/2012CN102690368A Preparation method of yeast beta-1,3-D-glucan derivative
09/26/2012CN102690342A Anti-cancer analgesic peptide VKVR, its preparation method and application
09/26/2012CN102690317A Derivant of 30-halogenated betulinic acid and preparation method and application thereof
09/26/2012CN102690313A Cholic acid-naphthoylimine compounds and application thereof
09/26/2012CN102690309A Floxuridine compound and preparation method and application thereof
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
09/26/2012CN102690275A Tetrahydrofuro-[3,4-c]pyranyl-4-ketone compound and its preparation method and use
09/26/2012CN102690270A Pyrimidine compound and purpose thereof
09/26/2012CN102690269A Trifluoro methyl substituted quinoline or quinoxaline compound and preparation method thereof, and pharmaceutical composition containing the compound and purpose thereof
09/26/2012CN102690264A 2-phenyl-3-substituted-imidazo[1,2-a]pyridine derivatives and preparation method thereof
09/26/2012CN102690261A Preparation method of 1,4-benzodioxan-containing 1,3,4-oxadiazole derivatives and use of the 1,4-benzdioxan-containing 1,3,4-oxadiazole derivatives in anti-cancer drugs
09/26/2012CN102690247A Furan compound, preparation method and application of same
09/26/2012CN102690238A Synthesis of barbituric acid derivative as RSK2 inhibitor and application thereof
09/26/2012CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
09/26/2012CN102688508A Targeting radioactive micro/nano fluid preparation
09/26/2012CN102688499A Albumin-polyethylene glycol-medicinal molecular conjugate
09/26/2012CN102688498A Taxanes-carboxymethyl chitosan amphiphilic macromolecule prodrug, micelle agent and freeze-dried micelle agent, as well as preparation methods thereof
09/26/2012CN102688496A CTX (Cyclophosphamide)-mediated targeting nanocarrier and nano medicine carrying system
09/26/2012CN102688495A Nano particle carrier having tumor and tumor-associated macrophage targeting multiple functions and preparation thereof
09/26/2012CN102688494A Preparation method of protein drug-carrying magnetic composite nano-material and application thereof
09/26/2012CN102688493A Pharmaceutical composition containing resveratrol, resveratrol derivative and Bc1-2 inhibitor, and application thereof
09/26/2012CN102688491A MET inhibitors for enhancing radiotherapy efficacy
09/26/2012CN102688490A Pharmaceutical composition containing evodiamine, evodiamine derivative and Bc1-2 inhibitor, and the application
09/26/2012CN102688489A Pharmaceutical composition containing triptolide, triptolide derivative and Bc1-2 inhibitor and application thereof
09/26/2012CN102688475A Anti-cancer extractive of wall gecko
09/26/2012CN102688472A Medicinal composition for preventing or relieving yang deficiency syndrome of tumor patient
09/26/2012CN102688460A Medicine combination for preventing or treating liver cancer
09/26/2012CN102688453A Traditional Chinese medicine composite for treating breast cancer
09/26/2012CN102688419A Xiaojian pill for eliminating hard masses
09/26/2012CN102688392A Baixueling
09/26/2012CN102688385A Traditional Chinese medicine for curing intermediate and terminal cancer
09/26/2012CN102688359A Traditional Chinese medicine composition for treating leukemia and preparation method thereof
09/26/2012CN102688317A Traditional Chinese medicine for treating liver cancer
09/26/2012CN102688312A Chinese medicinal herb agent with antitumoral effect and preparation method thereof
09/26/2012CN102688300A Pharmaceutical composition and usesthereof
09/26/2012CN102688291A Sculellaria barbata general flavone compound, oral preparations prepared from Sculellaria barbata general flavone compound and preparation methods respectively for Sculellaria barbata general flavone compound and oral preparations
09/26/2012CN102688271A Microwave-assisted extraction method of Artemisia gmelinii total flavone
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 2211